mesoblast
-
Recon
Mesoblast Cell Therapy Shows Disease Modifying Effects on Knee Osteoarthritis
NEW YORK and MELBOURNE, Australia, April 01, 2016 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced that results from…
Read More » -
Osiris Therapeutics receives $15 million cash payment from Mesoblast for Prochymal
Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading stem cell company focused on developing and marketing products to treat conditions in wound care, orthopedic…
Read More » -
Spine
Intervertebral Disc Repair Phase 2 Trial Update
MELBOURNE, Australia, April 17, 2012 /PRNewswire via COMTEX/ — Global regenerative medicine company Mesoblast Limited (asx:MSB) today announced that its…
Read More » -
Mesoblast Limited (ASX:MSB) Key Bone Repair Patent Granted In The United States
Melbourne, Mar 3, 2010 – (ABN Newswire< http://www.abnnewswire.net/index.asp?lang=>) – Australia’s regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY), today announced that…
Read More »